
Danaher Corp (DHR) - Financial and Strategic SWOT Analysis Review
Description
Danaher Corp (DHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Danaher Corp (Danaher) designs, manufactures, and markets medical products and services. It offers a wide range of testing instruments, medical diagnostic solutions, life science research tools, professional microscopes, reagents and mass spectrometry, genomic consumables, filtration and flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization businesses. The company operates manufacturing, sales, distribution, service and administrative facilities in Europe, Australia, Asia, and the Americas. The company distributes its products to customers in the Americas; Europe, the Middle East, Africa, and Asia-Pacific through direct sales personnel and independent distributors. Danaher is headquartered in Washington DC, the US.
Danaher Corp Key Recent Developments
Apr 22,2025: Danaher Announces Results for Quarter Ended March 28, 2025
Feb 20,2025: Danaher Adds Charles Lamanna to Board
Jan 29,2025: Danaher Reports Fourth Quarter and Full Year 2024 Results
Oct 22,2024: Danaher Announces Q3 2024 Results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Danaher Corp (Danaher) designs, manufactures, and markets medical products and services. It offers a wide range of testing instruments, medical diagnostic solutions, life science research tools, professional microscopes, reagents and mass spectrometry, genomic consumables, filtration and flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization businesses. The company operates manufacturing, sales, distribution, service and administrative facilities in Europe, Australia, Asia, and the Americas. The company distributes its products to customers in the Americas; Europe, the Middle East, Africa, and Asia-Pacific through direct sales personnel and independent distributors. Danaher is headquartered in Washington DC, the US.
Danaher Corp Key Recent Developments
Apr 22,2025: Danaher Announces Results for Quarter Ended March 28, 2025
Feb 20,2025: Danaher Adds Charles Lamanna to Board
Jan 29,2025: Danaher Reports Fourth Quarter and Full Year 2024 Results
Oct 22,2024: Danaher Announces Q3 2024 Results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
65 Pages
- Section 1 - About the Company
- Danaher Corp - Key Facts
- Danaher Corp - Key Employees
- Danaher Corp - Key Employee Biographies
- Danaher Corp - Major Products and Services
- Danaher Corp - History
- Danaher Corp - Company Statement
- Danaher Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Business Unit
- Section 2 – Company Analysis
- Company Overview
- Danaher Corp - Business Description
- Business Segment: Biotechnology
- Overview
- Performance
- Business Segment: Diagnostics
- Overview
- Performance
- Business Segment: Life Sciences
- Overview
- Performance
- Geographical Segment: All other
- Performance
- Geographical Segment: China
- Performance
- Geographical Segment: United States
- Performance
- R&D Overview
- Danaher Corp - Corporate Strategy
- Danaher Corp - SWOT Analysis
- SWOT Analysis - Overview
- Danaher Corp - Strengths
- Danaher Corp - Weaknesses
- Danaher Corp - Opportunities
- Danaher Corp - Threats
- Danaher Corp - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences, Oil & Gas Financial Deals and Alliances
- Danaher Corp, Medical Equipment, Deals By Year, 2019 to YTD 2025
- Danaher Corp, Medical Equipment, Deals By Type, 2019 to YTD 2025
- Danaher Corp, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Apr 22, 2025: Danaher Announces Results for Quarter Ended March 28, 2025
- Feb 20, 2025: Danaher Adds Charles Lamanna to Board
- Jan 29, 2025: Danaher Reports Fourth Quarter and Full Year 2024 Results
- Oct 22, 2024: Danaher Announces Q3 2024 Results
- Oct 22, 2024: Danaher Reports Third Quarter 2024 Results
- Sep 04, 2024: Danaher Confirms Third Quarter and Full Year 2024 Guidance
- Jul 23, 2024: Danaher Announces Q2 2024 Results
- Jul 17, 2024: Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development
- Jun 19, 2024: Danaher Names Julie Sawyer Montgomery as Executive Vice President for Diagnostics
- May 09, 2024: Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Danaher Corp, Key Facts
- Danaher Corp, Key Employees
- Danaher Corp, Key Employee Biographies
- Danaher Corp, Major Products and Services
- Danaher Corp, History
- Danaher Corp, Subsidiaries
- Danaher Corp, Business Unit
- Danaher Corp, Key Competitors
- Danaher Corp, Ratios based on current share price
- Danaher Corp, Annual Ratios
- Danaher Corp, Annual Ratios (Cont...1)
- Danaher Corp, Annual Ratios (Cont...2)
- Danaher Corp, Interim Ratios
- Danaher Corp, Medical Equipment, Deals By Year, 2019 to YTD 2025
- Danaher Corp, Medical Equipment, Deals By Type, 2019 to YTD 2025
- Danaher Corp, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Danaher Corp, Performance Chart (2020 - 2024)
- Danaher Corp, Ratio Charts
- Danaher Corp, Medical Equipment, Deals By Year, 2019 to YTD 2025
- Danaher Corp, Medical Equipment, Deals by Type, 2019 to YTD 2025
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.